Skip to McMaster Navigation Skip to Site Navigation Skip to main content
mcmaster university logo McMaster logo

Faculty of Science

Department of Chemistry & Chemical Biology

AstraZeneca moves to acquire Dr. Valliant founded Fusion Pharmaceuticals for $2.4 billion (US)

John Valliant with Fusion Pharmaceuticals banner

Read more at McMaster Daily News.

 Research

Related News

News Listing

Rullo Lab Reveals How Target Binding Accelerates Covalent Drug Reactions

Research

September 9, 2025

A graduate student, left, watches Tessella Biosciences co-founders David Gonzalez Martinez, centre, and Jose Moran-Mirabal, right, working with their new bioink, which can be used to print flexible, stable 3D structures at body temperature

McMaster Brighter World  ➚

CCB startup Tessella Biosciences creates 3D-printable ‘bioink’ that simulates lung tissue

Research

June 17, 2025

Prof. Britz-McKibbin looking at a computer screen in the lab

McMaster Brighter World  ➚

Britz-McKibbin team uncovers molecules that may influence early childhood development

Research

March 3, 2025